Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain

  1. Frías, C.
  2. Cortés, J.
  3. Seguí, M.Á.
  4. Oyagüez, I.
  5. Casado, M.Á.
Revue:
Clinical and Translational Oncology

ISSN: 1699-048X

Année de publication: 2010

Volumen: 12

Número: 10

Pages: 692-700

Type: Article

DOI: 10.1007/S12094-010-0579-4 GOOGLE SCHOLAR